Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols
- PMID: 9600345
- DOI: 10.1093/carcin/19.4.611
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols
Abstract
In order to study the biological activities of tea preparations and purified tea polyphenols, their growth inhibitory effects were investigated using four human cancer cell lines. Growth inhibition was measured by [3H]thymidine incorporation after 48 h of treatment. The green tea catechins (-)-epigallocatechin-3-gallate (EGCG) and (-)-epigallocatechin (EGC) displayed strong growth inhibitory effects against lung tumor cell lines H661 and H1299, with estimated IC50 values of 22 microM, but were less effective against lung cancer cell line H441 and colon cancer cell line HT-29 with IC50 values 2- to 3-fold higher. (-)-Epicatechin-3-gallate, had lower activities, and (-)-epicatechin was even less effective. Preparations of green tea polyphenols and theaflavins had higher activities than extracts of green tea and decaffeinated green tea. The results suggest that the growth inhibitory activity of tea extracts is caused by the activities of different tea polyphenols. Exposure of H661 cells to 30 microM EGCG, EGC or theaflavins for 24 h led to the induction of apoptosis as determined by an annexin V apoptosis assay, showing apoptosis indices of 23, 26 and 8%, respectively; with 100 microM of these compounds, the apoptosis indices were 82, 76 and 78%, respectively. Incubation of H661 cells with EGCG also induced a dose-dependent formation of H2O2. Addition of H2O2 to H661 cells caused apoptosis in a manner similar to that caused by EGCG. The EGCG-induced apoptosis in H661 cells was completely inhibited by exogenously added catalase (50 units/ml). These results suggest that tea polyphenol-induced production of H2O2 may mediate apoptosis and that this may contribute to the growth inhibitory activities of tea polyphenols in vitro.
Similar articles
-
Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction.Carcinogenesis. 2000 Nov;21(11):2035-9. doi: 10.1093/carcin/21.11.2035. Carcinogenesis. 2000. PMID: 11062165
-
Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.Cancer Lett. 1998 Jul 17;129(2):173-9. doi: 10.1016/s0304-3835(98)00108-6. Cancer Lett. 1998. PMID: 9719459
-
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.Cancer Res. 1999 Jan 1;59(1):44-7. Cancer Res. 1999. PMID: 9892181
-
Green tea: nature's defense against malignancies.Crit Rev Food Sci Nutr. 2009 May;49(5):463-73. doi: 10.1080/10408390802145310. Crit Rev Food Sci Nutr. 2009. PMID: 19399671 Review.
-
Green tea polyphenols: biology and therapeutic implications in cancer.Front Biosci. 2007 Sep 1;12:4881-99. doi: 10.2741/2435. Front Biosci. 2007. PMID: 17569617 Review.
Cited by
-
Plant-Based Anticancer Compounds With a Focus on Breast Cancer.Cancer Rep (Hoboken). 2024 Oct;7(10):e70012. doi: 10.1002/cnr2.70012. Cancer Rep (Hoboken). 2024. PMID: 39453820 Free PMC article. Review.
-
Anti-Cancer Properties of Theaflavins.Molecules. 2021 Feb 13;26(4):987. doi: 10.3390/molecules26040987. Molecules. 2021. PMID: 33668434 Free PMC article. Review.
-
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.Int J Oncol. 2013 Jul;43(1):39-49. doi: 10.3892/ijo.2013.1934. Epub 2013 May 9. Int J Oncol. 2013. PMID: 23661254 Free PMC article.
-
Anticancer Efficacy of Polyphenols and Their Combinations.Nutrients. 2016 Sep 9;8(9):552. doi: 10.3390/nu8090552. Nutrients. 2016. PMID: 27618095 Free PMC article. Review.
-
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.Blood. 2006 Oct 15;108(8):2804-10. doi: 10.1182/blood-2006-05-022814. Epub 2006 Jun 29. Blood. 2006. PMID: 16809610 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical